Smooth Drug Development offers a full range of clinical trial, drug registration and post-marketing services, including consulting, development of registration strategy, conduct of clinical studies and pharmacovigilance in Europe and Asia. We cover wide geography: -EAEA Region -Europe -Latvia -Lithu...
Use this information to figure out if this company is an ideal customer for you.
+7.812.913.04.23
2711 Centerville Road
Wilmington, 19808
51 - 200 Employees
$50M - $100M
linkedin.com/company/smooth-drug-development
The most common Smooth Drug Development, Next Generation E-CRO in Europe and Asia email format is [f][last] (ex. jdoe@smoothdd.com), currently being used by 61% of Smooth Drug Development, Next Generation E-CRO in Europe and Asia business email addresses. There are 4 email formats used by Smooth Drug Development, Next Generation E-CRO in Europe and Asia.
Smooth Drug Development, Next Generation E-CRO in Europe and Asia's CEO is Dmitry Morozovsky
Smooth Drug Development, Next Generation E-CRO in Europe and Asia's HQ is located at 2711 Centerville Road, Wilmington
Smooth Drug Development, Next Generation E-CRO in Europe and Asia's phone number is +7.812.913.04.23
Smooth Drug Development, Next Generation E-CRO in Europe and Asia's official website is smoothdd.com
Smooth Drug Development, Next Generation E-CRO in Europe and Asia's revenue is $50M - $100M
Smooth Drug Development, Next Generation E-CRO in Europe and Asia has 51 - 200 employees
Smooth Drug Development, Next Generation E-CRO in Europe and Asia is in the industry of: Pharmaceuticals
